Company intelligence / Profile preview

SPH Ke Yuan Xinhai Pharmaceutical

Beijing, Beijing, Chinaen.kybeijing.com ↗

Ownership: Private
Development stage: Other

Overview

The company is a major distributor and importer for medicines, vaccines, devices in China, with strong supply chain and distribution infrastructure. Partners with international companies (e.g., Orphalan) to commercialize innovative drugs such as trientine tetrahydrochloride for Wilson’s disease in China, and also involved in new drug development and innovative supply chain services. Pipeline includes 50 new drug projects (42 innovative, 8 improved), spanning preclinical to Phase 3 and commercial stages. Several partnerships accelerate market entry and patient access.

Therapeutic areas: Women's HealthRare DiseasesOther
Modalities: Small moleculeBiologicCell therapyMicrobial therapyVaccine
Industry: Biotech

Partnerships

Orphalan (Wilson’s disease drug commercialization in China)Asieris (import agency and distribution for APL-1702)Multiple strategic partnerships with domestic and international pharma companies

Beyond the preview

Go deeper on SPH Ke Yuan Xinhai Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on SPH Ke Yuan Xinhai Pharmaceutical.